Trial · NCT04652102
Adverse events432
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 432
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Chills | General disorders | CVnCoV 12 μg Vaccine | 1,439 | 19,787 | 2,065 |
| other | Chills | General disorders | Placebo | 240 | 19,753 | 286 |
| other | Fatigue | General disorders | CVnCoV 12 μg Vaccine | 1,893 | 19,787 | 3,200 |
| other | Fatigue | General disorders | Placebo | 1,019 | 19,753 | 1,483 |
| other | Injection site pain | General disorders | CVnCoV 12 μg Vaccine | 2,008 | 19,787 | 3,231 |
| other | Injection site pain | General disorders | Placebo | 537 | 19,753 | 644 |
| other | Pyrexia | General disorders | CVnCoV 12 μg Vaccine | 1,305 | 19,787 | 1,700 |
| other | Pyrexia | General disorders | Placebo | 95 | 19,753 | 102 |
| other | Myalgia | Musculoskeletal and connective tissue disorders | CVnCoV 12 μg Vaccine | 1,728 | 19,787 | 2,588 |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Placebo | 509 | 19,753 | 634 |
| other | Headache | Nervous system disorders | CVnCoV 12 μg Vaccine | 2,310 | 19,787 | 3,911 |
| other | Headache | Nervous system disorders | Placebo | 1,225 | 19,753 | 1,805 |
| serious | Appendicitis | Infections and infestations | CVnCoV 12 μg Vaccine | 8 | 19,787 | |
| serious | Appendicitis | Infections and infestations | Placebo | 3 | 19,753 | |
| serious | COVID-19 pneumonia | Infections and infestations | CVnCoV 12 μg Vaccine | 5 | 19,787 | |
| serious | COVID-19 pneumonia | Infections and infestations | Placebo | 4 | 19,753 | |
| serious | COVID-19 | Infections and infestations | CVnCoV 12 μg Vaccine | 1 | 19,787 | |
| serious | COVID-19 | Infections and infestations | Placebo | 3 | 19,753 | |
| serious | Urinary tract infection | Infections and infestations | CVnCoV 12 μg Vaccine | 2 | 19,787 | |
| serious | Urinary tract infection | Infections and infestations | Placebo | 1 | 19,753 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04652102/events